Stocktoria
Polaryx Therapeutics, Inc. PLYX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2026-02-02
Polaryx Therapeutics, Inc. statistics & valuation
Market cap$113.6M
P / B24.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -173.8% | -607.0% |
| Return on equity | -196.8% | -644.2% |
| Current ratio | 8.55 | 17.30 |
Source: SEC EDGAR filings · CIK 0002075320 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.